RxDoctor Payments Data

Haseena Mirza

Physician Assistant · Anaheim, CANPI 1750552444

Payments from drug & device makers

$2,799in general payments, 2019–2025

Across 100 payments — averaging $27.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$681
  • Dexcom, Inc.$367
  • Novo Nordisk$298
  • Lilly USA, LLC$278
  • Amgen$253
  • Aspira Women's Health Inc$214
  • plus $707 from 14 others

What the payments were for

  • Food & beverage$2,799100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,799 in reported general payments places this provider in the 85th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide138$161,024
JardianceEmpagliflozin98$92,288
TrulicityDulaglutide35$55,725
MounjaroTirzepatide49$53,033
InvokanaCanagliflozin21$31,970
Synjardy XrEmpagliflozin/Metformin Hcl37$31,185
RybelsusSemaglutide26$29,748
JanuviaSitagliptin Phosphate29$25,633
TradjentaLinagliptin22$15,497
FarxigaDapagliflozin Propanediol11$10,865
Tresiba Flextouch U-100Insulin Degludec16$7,385
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/711$6,527
Humalog Kwikpen U-100Insulin Lispro30$6,089
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$4,474
VascepaIcosapent Ethyl13$4,076

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$298$190,772164 claims
Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta$79$138,971157 claims
Lilly USA, LLCTrulicity, Mounjaro$278$108,75884 claims
AstraZenecaFarxiga$18$10,86511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Anaheim

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →